Large animal models of heart failure

Australian and New Zealand Journal of Medicine

Volumn 29, Issue 3, 1999, Pages 395-402

  Power, J M ^a   Tonkin, A M ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b NATIONAL HEART FOUNDATION OF AUSTRALIA   (Australia)

Author keywords

Heart failure; Large animal models

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CATECHOLAMINE; DOXORUBICIN;

ANIMAL MODEL; AORTA CONSTRICTION; AORTA VALVE REGURGITATION; AORTOCAVAL FISTULA; CARDIOTOXICITY; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; HEART EDEMA; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART VENTRICLE PACING; MEDICAL ETHICS; MEDICAL RESEARCH; MITRAL VALVE REGURGITATION; NONHUMAN; PULMONARY VALVE STENOSIS; TACHYCARDIA;

EID: 0032998342     PISSN: 00048291     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.1999.tb00734.x     Document Type: Conference Paper

References (78)

1. 1. Gillium RF, Folson AR, Blackburn H. The decline in coronary heart disease mortality: old questions and new facts. Am J Med 1984; 76: 1055-65.
2. 2. Jensen DN, Wagner BK, Rose AG, Mehra R, Edwards JE. Which animal species should be used to investigate ablation catheters designed to create long, linear, atrial 'maze' lesions? PACE 1997; 20: 1076.
3. 3. Grogan M, Smith HC, Gersh BJ, Wood DL. Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. Am J Cardiol 1992; 69: 1570-3.
4. 4. Peters KG, Kienzle MG. Severe cardiomyopathy due to chronic rapidly conducted atrial fibrillation: complete recovery after restoration of sinus rhythm. Am J Med 1988; 85: 242-4.
5. 5. Bertil Olsson S, Blomstrom P, Sabel KG, William Olsson G. Incessant ectopic atrial tachycardia: successful surgical treatment with regression of dilated cardiomyopathy picture. Am J Cardiol 1984; 53: 1465-6.
6. 6. Fyfe DA, Gillette PC, Crawford FJ, Kline CH. Resolution of dilated cardiomyopathy after surgical ablation of ventricular tachycardia in a child. J Am Coll Cardiol 1987; 9: 231-4.
7. 7. Twidale N, Sutton K, Bartlett L. Effects of cardiac performance of atrioventricular node catheter ablation using radiofrequency current for drug-refractory atrial arrhythmias. PACE 1993; 16: 1275-84.
8. 8. Whipple GH, Sheffield LT, Woodman EG, Theophillis C, Friedman S. Reversible congestive heart failure due to chronic rapid stimulation of the normal heart. Proc N Engl Cardiovasc Soc 1962; 20: 39-40.
9. 9. Armstrong PW, Moe GW, Howard RJ, Grima EA, Cruz TF. Structural remodelling in heart failure: gelatinase induction. Can J Cardiol 1994; 10: 214-20.
10. 10. Binkley PF, Nunziata E, Haas GJ, Nelson SD, Cody RJ. Parasympathetic withdrawal is an integral component of autonomic imbalance in congestive heart failure: demonstration in human subjects and verification in a paced canine model of ventricular failure. J Am Coll Cardiol 1991; 18: 464-72.
11. 11. Hoit BD, Shao Y, Gabel M, Walsh RA. Left atrial mechanical and biochemical adaptation to pacing induced heart failure. Cardiovasc Res 1995; 29: 469-74.
12. 12. Moe GW, Grima EA, Angus C et al. Response of atrial natriuretic factor to acute and chronic increases of atrial pressures in experimental heart failure in dogs. Role of changes in heart rate, atrial dimension, and cardiac tissue concentration. Circulation 1991; 83: 1780-7.
13. 13. Naitoh M, Suzuki H, Murakami M et al. Effects of oral AVP receptor antagonists OPC-21268 and OPC-31260 on congestive heart failure in conscious dogs. Am J Physiol 1994; 267: H2245-H54.
14. 14. Riegger GA, Elsner D, Hildenbrand J, Koch K, Kromer EP. Prostaglandins, renin and atrial natriuretic peptide in the control of the circulation and renal function in heart failure in the dog. Prog Clin Biol Res 1989; 301: 455-8.
15. 15. Power J, Beacom G, Alferness C, Raman J, Tonkin A. Susceptibility to atrial fibrillation in an ovine heart failure model. PACE 1996; 19: 629.
16. 16. Fitzpatrick MA, Rademaker MT, Frampton CM et al. Hemodynamic and hormonal effects of renin inhibition in ovine heart failure. Am J Physiol 1990; 258: H1625-31.
17. 17. Fitzpatrick MA, Nicholls MG, Espiner EA, Ikram H, Bagshaw P, Yandle TG. Neurohumoral changes during onset and offset of ovine heart failure: role of ANP. Am J Physiol 1989; 256: H1052-H9.
18. 18. Charles CJ, Kaaja RJ, Espiner EA et al. Natriuretic peptides in sheep with pressure overload left ventricular hypertrophy. Clin Exp Hyperten 1996; 18: 1051-71.
19. 19. Eising GP, Hammond HK, Helmer GA, Gilpin E, Ross JJ. Force-frequency relations during heart failure in pigs. Am J Physiol 1994; 267: H16-23.
20. 20. Chow E, Woodard JC, Farrar DJ. Rapid ventricular pacing in pigs: an experimental model of congestive heart failure. Am J Physiol 1990; 257: H1878-84.
21. 21. Hebbar L, Dorman BH, Clair MJ, Roy RC, Spinale FG. Negative and selective effects of propofol on isolated swine myocyte contractile function in pacing-induced congestive heart failure. Anesthesiology 1997; 86: 649-59.
22. 22. Shannon RP, Komamura K, Stambler BS, Bigaud M, Manders WT, Vatner SF. Alterations in myocardial contractility in conscious dogs with dilated cardiomyopathy. Am J Physiol 1991; 260: H1903-H11.
23. 23. Wilson JR, Douglas P, Hickey WF et al. Experimental congestive heart failure produced by rapid ventricular pacing in the dog: cardiac effects. Circulation 1987; 75: 857-67.
24. 24. Ohno M, Cheng CP, Little WC. Mechanism of altered patterns of left ventricular filling during the development of congestive heart failure. Circulation 1994; 89: 2241-50.
25. 25. Moe GW, Grima EA, Howard RJ, Armstrong PW. Biatrial appendage hypertrophy but not ventricular hypertrophy: a unique feature of canine pacing-induced heart failure. J Cardiac Failure 1996; 2: 127-32.
26. 26. Howard RJ, Stopps TP, Moe GW, Gotlieb A, Armstrong PW. Recovery from heart failure: structural and functional analysis in a canine model. Can J Physiol Pharm 1988; 66: 1505-12.
27. 27. Komamura K, Shannon RP, Ihara T et al. Exhausation of Frank-Starling mechanism in conscious dogs with heart failure. Am J Physiol 1993; 265: H1119-H31.
28. 28. Calderone A, Bouvier M, Li K, Juneau C, de CJ, Rouleau JL. Dysfunction of the beta-and alpha-adrenergic systems in a model of congestive heart failure. The pacing-overdrive dog. Circ Res 1991; 69: 332-43.
29. 29. Moe GW, Stopps TP, Angus C, Forster C, De BA, Armstrong PW. Alterations in serum sodium in relation to atrial natriuretic factor and other neuroendocrine variables in experimental pacing-induced heart failure. J Am Coll Cardiol 1989; 13: 173-9.
30. 30. Riegger GA, Elsner D, Kromer EP et al. Atrial natriuretic peptide in congestive heart failure in the dog: plasma levels, cyclic guanosine monophosphate, ultrastructure of atrial myoendocrine cells, and hemodynamic, hormonal, and renal effects. Circulation 1988; 77: 398-406.
31. 31. Riegger AJ. Role of vasopressin in experimental heart failure. Eur Heart J 1988; 1988; 9 (Suppl. H): 7-11.
32. 32. Riegger AJ. Hormones in heart failure-regulation and counter-regulation. Eur Heart J 1991; 9 (Suppl. D): 7-190-8.
33. 33. Perrella MA, Schwab TR, O'Murchu B et al. Cardiac atrial natriuretic factor during evolution of congestive heart failure. Am J Physiol 1992; 262: H1248-H55.
34. 34. Moe GW, Montgomery C, Howard RJ, Grima EA, Armstrong PW. Left ventricular myocardial blood flow, metabolism, and effects of treatment with enalapril: further insights into the mechanisms of canine experimental pacing-induced heart failure. J Lab Clin Med 1993; 121: 294-301.
35. 35. Simmons WW, Moe GW, Grima EA, Howard RJ. Armstrong PW. Myocardial energetics and blood flow in acute rapid ventricular pacing. Can J Physiol Pharm 1994; 72: 6-10.
36. 36. Shannon RP, Komamura K, Shen YT, Bishop SP, Vatner SF. Impaired regional subendocardial coronary flow reserve in conscious dogs with pacing-induced heart failure. Am J Physiol 1993; 265: H801-10.
37. 37. Perreault CL, Shannon RP, Komamura K, Vatner SF, Morgan JP. Abnormalities in intracellular calcium regulation and contractile function in myocardium from dogs with pacing-induced heart failure. J Clin Invest 1992; 89: 932-8.
38. 38. O'Brien PJ, Moe GW, Nowack LM, Grima EA, Armstrong PW. Sarcoplasmic reticulum Ca-release channel and ATP-synthesis activities are early myocardial markers of heart failure produced by rapid ventricular pacing in dogs. Can J Physiol Pharm 1994; 72: 999-1006.
39. 39. Moe GW, Stopps TP, Howard RJ, Armstrong PW. Early recovery from heart failure: insights into the pathogenesis of experimental chronic pacing-induced heart failure. J Lab Clin Med 1988; 112: 426-32.
40. 40. Redfield MM, Aarhus LL, Wright RS, Burnett JC. Cardiorenal and neurohumoral function in a canine model of early left ventricular dysfunction. Circulation 1993; 87: 2016-22.
41. 41. Jugdutt B, Becker L, Hutchins G. Early changes in collateral blood flow after coronary occlusion and relation to infarction in the conscious dog. Am J Physiol 1979; 237: H371-H80.
42. 42. Millner RW, Mann JM, Pearson I, Pepper JR. Experimental model of left ventricular failure. Ann Thor Surg 1991; 52: 78-83.
43. 43. Jugdutt BI, Tang SB, Khan MI, Basualdo CA. Functional impact on remodeling during healing after non-Q-wave versus Q-wave anterior myocardial infarction in the dog. J Am Coll Cardiol 1992; 20: 722-31.
44. 44. Hammond HK, Roth DA, McKirnan MD, Ping P. Regional myocardial downregulation of the inhibitory guanosine triphosphate-binding protein (Gi alpha 2) and beta-adrenergic receptors in a porcine model of chronic episodic myocardial ischaemia. J Clin Invest 1993; 92: 2644-52.
45. 45. Hammond HK, McKirnan MD. Effects of dobutamine and arbutamine on regional myocardial function in a porcine model of myocardial ischaemia. J Am Coll Cardiol 1994; 23: 475-82.
46. 46. Sabbah HN, Stein PD, Kono T et al A canine model of chronic heart failure produced by multiple sequential coronary microembolizations. Am J Physiol 1991; 260: H1379-H84.
47. 47. Huang YF, Kawaguchi O, Yuasa TBZ, Carrington R, Horam C, Hunyor S. Stable ovine congestive heart failure (CHF) model suitable for LVAD assessment. ASAIO 1997; 43: 28. (Abstr.).
48. 48. Sabbah HN, Goldberg AD, Schoels W et al. Spontaneous and inducible ventricular arrhythmias in a canine model of chronic heart failure: relation to haemodynamics and sympathoadrenergic activation. Eur Heart J 1992; 13: 1562-72.
49. 49. Sabbah HN, Sharov V, Riddle JM, Kono T, Lesch M, Goldstein S. Mitochondrial abnormalities in myocardium of dogs with chronic heart failure. J Mol Cell Cardiol 1992; 24: 1333-47.
50. 50. Sabbah HN, Kono T, Rosman H, Jafri S, Stein PD, Goldstein S. Left ventricular shape: a factor in the etiology of functional mitral regurgitation in heart failure. Am Heart J 1992; 123: 961-6.
51. 51. Sabbah HN, Kono T, Stein PD, Mancini GB, Goldstein S. Left ventricular shape changes during the course of evolving heart failure. Am J Physiol 1992; 263: H266-H70.
52. 52. Sabbah HN, Shimoyama H, Kono T et al. Effects of long-term monotherapy with enalapril, metoprolol, and digoxin on the progression of left ventricular dysfunction and dilation in dogs with reduced ejection fraction. Circulation 1994; 89: 2852-9.
53. 53. Sabbah HN, Sharov VG, Lesch M, Goldstein S. Progression of heart failure: a role for interstitial fibrosis. Mol Cell Biochem 1995; 147: 29-34.
54. 54. Sabbah HN, Shimoyama H, Sharov VG et al. Effects of ACE inhibition and beta-blockade on skeletal muscle fiber types in dogs with moderate heart failure. Am J Physiol 1996; 270: H115-23.
55. 55. Goldstein S, Sharov VG, Cook JM, Sabbah HN. Ventricular remodeling: insights from pharmacologic interventions with angiotensin-converting enzyme inhibitors. J Mol Cell Biochem 1995; 147: 51-5.
56. 56. Gengo PJ, Sabbah HN, Steffen RP et al. Myocardial beta adrenoceptor and voltage sensitive calcium channel changes in a canine model of chronic heart failure. J Mol Cell Cardiol 1992; 24: 1361-9.
57. 57. McDonald KM, Yoshiyama M, Francis GS, Ugurbil K, Cohn JN, Zhang J. Myocardial bioenergetic abnormalities in a canine model of left ventricular dysfunction. J Am Coll Cardiol 1994; 23: 786-93.
58. 58. McDonald KM, Garr M, Carlyle PF et al. Relative effects of alpha 1-adrenoceptor blockade, converting enzyme inhibitor therapy, and angiotensin II subtype 1 receptor blockade on ventricular remodeling in the dog. Circulation 1994; 90: 3034-46.
59. 59. McDonald KM, Rector T, Carlyle PF, Francis GS, Cohn JN. Angiotensin-converting enzyme inhibition and beta-adrenoceptor blockade regress established ventricular remodeling in a canine model of discrete myocardial damage. J Am Coll Cardiol 1994; 24: 1762-8.
60. 60. McDonald KM, Mock J, D'Aloia A et al. Bradykinin antagonism inhibits the antigrowth effect of converting enzyme inhibition in the dog myocardium after discrete transmural myocardial necrosis. Circulation 1995; 91: 2043-8.
61. 61. McDonald KM, Francis GS, Matthews J, Hunter D, Cohn JN. Long-term oral nitrate therapy prevents chronic ventricular remodeling in the dog. J Am Coll Cardiol 1993; 21: 514-22.
62. 62. Cheng W, Justicz AG, Soberman MS, Alazraki NP, Santamore WP, Sink JD. Effects of dynamic cardiomyoplasty on indices of left ventricular systolic and diastolic function in a canine model of chronic heart failure. J Thor Cardiovasc Surg 1992; 103: 1207-13.
63. 63. Cheng W, Michele JJ, Spinale FG, Sink JD, Santamore WP. Effects of cardiomyoplasty on biventricular function in canine chronic heart failure. Ann Thorac Surg 1993; 55: 893-901.
64. 64. Magovern JA, Christlieb IY, Badylak SF, Lantz GC, Kao RL. A model of left ventricular dysfunction caused by intracoronary adriamycin. Ann Thorac Surg 1992; 53: 861-3.
65. 65. Movahed A, Reeves WC, Mehta PM, Gilliand MG, Mozingo SL, Jolly SR. Norepinepherine induced left ventricular dysfunction in anaesthetised and conscious sedated dogs. Int J Cardiol 1994; 45: 23-34.
66. 66. Carabello BA, Nakano K, Corin W, Biedermann R, Spann JF. Left ventricular function in experimental volume overload hypertrophy. Am J Physiol 1989; 256: H974-H81.
67. 67. Nakano K, Swindle MM, Spinale F et al. Depressed contractile function due to canine mitral valve regurgitation improves after correction of volume overload. J Clin Invest 1991; 87: 2077-86.
68. 68. Kannel WB, Castelli WP, McNamara PM, McKee PA, Feinleib M. Role of blood pressure in the development of congestive heart failure: The Framingham Study. N Engl J Med 1972; 287: 781-7.
69. 69. Hasebe N, Hittinger L, Kohin S, Shen YT, Graham RM, Vatner SF. Effects of hypertrophy on left atrial and ventricular compliance and plasma ANF levels in conscious dogs. Am J Physiol 1995; 268: H781-9.
70. 70. Hittinger L, Shannon RP, Bishop SP, Gelpi RJ, Vatner SF. Subendomyocardial exhaustion of blood flow reserve and increased fibrosis in conscious dogs with heart failure. Circ Res 1989; 65: 971-80.
71. 71. Hittinger L, Shannon RP, Kohin S et al. Isoproterenol-induced alterations in myocardial blood flow, systolic and diastolic function in conscious dogs with heart failure. Circulation 1989; 80: 658-68.
72. 72. Aoyagi T, Mirsky I, Flanagan MF, Currier JJ, Colan SD, Fujii AM. Myocardial function in immature and mature sheep with pressure-overload hypertrophy. Am J Physiol 1992; 262: H1036-H48.
73. 73. Beardow A, Buchanan JW. Chronic mitral valve disease in Cavalier King Charles Spaniels: 95 cases (1987-1991). JAVMA 1993; 203: 1023-9.
74. 74. Calvert CA, Hall G, Jacobs G, Pickus C. Clinical and pathologic findings in Doberman pinschers with occult cardiomyopathy that died suddenly or developed congestive heart failure: 54 cases (1984-1991). JAVMA 1997; 210: 505-11.
75. 75. Freeman LM, Michel KE, Brown DJ et al. Idiopathic dilated cardiomyopathy in Dalmatians: nine cases (1990-1995). JAVMA 1996; 209: 1592-6.
76. 76. Anonymous. Acute and short-term hemodynamic, echocardiographic, and clinical effects of enalapril maleate in dogs with naturally acquired heart failure: results of the Invasive Multicenter PROspective Veterinary Evaluation of Enalapril study. The IMPROVE Study Group. J Vet Int Med 1995; 9: 234-42.
77. 77. Anonymous. Controlled clinical evaluation of enalapril in dogs with heart failure: results of the Cooperative Veterinary Enalapril Study Group. The COVE Study Group. J Vet Int Med 1995; 9: 243-52.
78. 78. Corin WJ, Swindle MM, Spann JF et al. The mechanism of decreased forward stroke volume in children and swine with ventricular septal defect and failure to thrive. J Clin Invest 1988; 82: 544-51.